Bora Pharmaceuticals Co., LTD. (TPE:6472)

Market Cap	79.47B
Revenue (ttm)	20.87B
Net Income (ttm)	4.62B
Shares Out	103.21M
EPS (ttm)	41.39
PE Ratio	14.47
Forward PE	17.60
Dividend	14.00 (1.82%)
Ex-Dividend Date	Jun 20, 2025

Volume	1,139,604
Average Volume	1,095,040
Open	790.00
Previous Close	767.00
Day's Range	768.00 - 795.00
52-Week Range	562.00 - 975.00
Beta	0.66
RSI	60.53
Earnings Date	May 9, 2025

About TPE:6472

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6472

Financial Performance

In 2024, TPE:6472's revenue was 19.25 billion, an increase of 35.53% compared to the previous year's 14.20 billion. Earnings were 3.94 billion, an increase of 29.99%.